Blood transfusion requirements in elective breast reconstruction surgery

被引:10
作者
Al-Benna, Sammy [1 ]
Rajgarhia, Prachi [1 ]
机构
[1] St Johns Hosp Howden, Dept Plast Surg, Livingston, Scotland
关键词
Blood transfusion; Breast reconstruction; AUDIT; HIP;
D O I
10.1016/j.breast.2010.05.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Excess-ordering of cross-matched blood ill preparation for elective surgery is expensive with associated blood shortages and time-expired wastage. Although, the maximum surgical blood order schedule (MSBOS) for breast reconstruction recommends pre-operative cross-match of 2-6 units of red cell concentrate, there is no data confirming whether this guideline is observed in practice or whether compliance results ill improved outcome. The aim of this study was to examine the utility of this MSBOS in clinical practice by assessing its performance in a validation set of patients. Materials and Methods: Over a three year period, 49 patients undergoing 50 consecutive elective breast reconstruction surgery were assessed for demographic data, surgical information and hematological/transfusion data to compare the number of units of blood cross-matched with those subsequently transfused for elective breast reconstruction surgery. This was in lieu of updating the current maximal surgical blood order schedule of cross-matching 2-6 units pre-operatively. Results: Fifty elective operations were undertaken during the study period with a zero pen-operative blood transfusion requirement and a 8% post-operative blood transfusion requirement. Pre-operative cross-match to transfusion ratio was unacceptably high with a time-expired blood wastage of 8.7%. Discussion: These data thus indicate that adoption of a type and screen policy is satisfactory for haemorrhage risk management of elective breast reconstruction. The MSBOS is not designed to predict post-surgery blood needs and a requirement based blood ordering protocol will optimise blood utilisation efficiency. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:475 / 478
页数:4
相关论文
共 17 条
[1]  
Anderson W., 2001, Economic Affairs, V12, P14
[2]  
CALLA T, 1996, HDB TRANSFUSION MED, P65
[3]   Three-year single institution audit on transfusion requirements in oncology patients [J].
Dernedde, U. ;
Dernedde, R. ;
Shepstone, L. ;
Barrett, A. .
CLINICAL ONCOLOGY, 2007, 19 (04) :223-227
[4]   RISKS, OPTIONS, AND INFORMED CONSENT FOR BLOOD-TRANSFUSION IN ELECTIVE SURGERY [J].
GOODNOUGH, LT ;
SHUCK, JM .
AMERICAN JOURNAL OF SURGERY, 1990, 159 (06) :602-609
[5]  
Knowles S., 2007, Transfusion Alternatives in Transfusion Medicine, V9, P2, DOI 10.1111/j.1778-428X.2007.00062.x
[6]  
Kurdy NMG, 1996, ANN CHIR GYNAECOL FE, V85, P86
[7]   Audit of blood transfusion in elective breast cancer surgery - do we need to group and save pre-operatively [J].
Malik, Hassan ;
Bishop, Hugh ;
Winstanley, John .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2008, 90 (06) :472-473
[8]  
McClelland B, 1996, HDB TRANSFUSION MED, P35
[9]  
MEAD JH, 1980, AM J CLIN PATHOL, V74, P223
[10]  
Murphy W G, 1995, J R Coll Surg Edinb, V40, P10